Treatment and alcohol;Hépatite C et alcool

Gastroenterologie Clinique et Biologique

Volumn 26, Issue SPEC. 2, 2002, Pages

  Perlemuter, Gabriel ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; LIVER ENZYME;

ALCOHOL CONSUMPTION; ALCOHOLISM; APOPTOSIS; CONFERENCE PAPER; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PREVALENCE; SEROTYPE; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

ALANINE TRANSAMINASE; ALCOHOLISM; ANTIVIRAL AGENTS; APOPTOSIS; BIOPSY; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DRUG THERAPY, COMBINATION; ENZYME TESTS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; ODDS RATIO; PREVALENCE; RIBAVIRIN; RISK FACTORS; TIME FACTORS; VIRAL LOAD;

EID: 0036261952     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. High incidence of antibodies to hepatitis C virus in alcoholic cirrhosis: Fact or fiction?
2. Serological and histological aspects of hepatitis C virus infection in alcoholic patients
3. Chronic hepatitis C in alcoholic patients: Prevalence, genotypes, and correlation to liver disease
4. Alcoholism is associated with hepatitis C but not hepatitis B in an urban population
5. Relevance of anti-HCV reactivity in patients with alcoholic hepatitis
6. Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease
7. Relationship between alcoholic liver disease and HCV infection
8. Influence of hepatitis C status on alcohol consumption in opiate users in treatment
9. Drinking habits of subjects with hepatitis C virus-related chronic liver disease: Prevalence and effect on clinical, virological and pathological aspects
10. Clinical impact of drug addiction in alcoholics
11. Intravenous drug abuse - The major route of hepatitis C virus transmission among alcohol-dependent individuals?
12. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors
13. Contribution of hepatitis C virus to the progression of alcoholic liver disease
14. Hepatitis C serotypes in nonalcoholic and alcoholic patients
15. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C
16. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C
17. Chronic hepatitis C: Effect of alcohol on hepatitic activity and viral titre
18. Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases
19. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients
20. Influence of chronic alcohol abuse on hepatitis C virus replication
21. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection
22. Alcohol consumption enhances intrahepatic hepatitis C virus replication
23. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids
24. Ethanol inhibition: The humoral and cellular immune response to hepatitis C virus NS5 protein after genetic immunization
25. Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: Involvement of TNF-alpha receptor 1-independent and -dependent mechanisms
26. Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection
27. Alcohol intake increases hepatitis C virus-induced hepatocellular injury
28. Consumption of alcohol in the presence of hepatitis C virus is an additive risk for liver damage
29. A histopathological study of alcoholics with chronic HCV infection: Comparison with chronic hepatitis C and alcoholic liver disease
30. Effects of alcohol consumption on histological changes in chronic hepatitis C: A clinicopathological study
31. Hepatitis C viremia and anti-HCV antibodies in alcoholics
32. The effect of light drinking on HCV liver disease: The jury is still out
33. Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection
34. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma - Its relationship to alcohol drinking and the age of transfusion
35. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease
36. Hepatitis C and alcohol
37. Natural history of liver fibrosis progression in patients with chronic hepatitis C
38. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection
39. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
40. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case-control study
41. Impact of alcohol on the histological and clinical progression of hepatitis C infection
42. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study
43. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis
44. Lack of interaction between hepatitis C virus and alcohol in the pathogenesis of cirrhosis. A statistical study
45. Chronic liver disease: Do alcohol and hepatitis C virus interact
46. Estimating progression to cirrhosis in chronic hepatitis C virus infection
47. Hepatitis C and alcohol
48. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C
49. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2,215 patients
50. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case-control study in Italy. Brescia HCC Study
51. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: The role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study
52. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis
53. Biological responses to administered interferon in alcoholics
54. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis
55. Interferon therapy for chronic hepatitis C in habitual drinkers: Comparison with chronic hepatitis C in infrequent drinkers
56. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers